Sarepta Therapeutics ( NASDAQ: SRPT) faces an “arduous and treacherous path” to bring its gene therapy Elevidys back to market, according to a STAT report citing a senior FDA official, suggesting the ...

Broader markets advanced at open. The NSE Nifty Midcap 150 and NSE Nifty Smallcap 250 were trading 0.10% and 0.32% higher, respectively.

London stocks had pared gains by midday on Friday, with GSK under the cosh. The FTSE 100 was flat at 8,971.33, having ...

US and European equity-index futures advanced, indicating a record-extending global stock rally may have further to run as ...